Skip to content

Daniel Meader

Vice President at Trinity Nuclein Series C Investors.

Raised on Trinity Nuclein Series C Investors filings

$2.3M

of $15M offered across 1 Form D filing

Form D filings
1
Last filing
Feb 28, 2025

Company

Trinity Nuclein Series C Investors

Healthcare · Southlake, TX

Investment vehicle backing a rapid PCR test maker

Investors
23
Founded
2025
Still open
$12.7M

Trinity Nuclein Series C Investors filings

  • EquityFiled Feb 28, 2025Form D
    $2.3M/ $15M